HYPERPHAGIA
Clinical trials for HYPERPHAGIA explained in plain language.
Never miss a new study
Get alerted when new HYPERPHAGIA trials appear
Sign up with your email to follow new studies for HYPERPHAGIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for rare hunger disorder: Long-Term drug trial underway
Disease control TerminatedThis study tests whether ARD-101 can safely reduce extreme hunger and food-related behaviors in people with Prader-Willi syndrome over 12 months. About 90 participants who completed a prior study will take the drug daily and visit the clinic regularly. The goal is to see if the d…
Matched conditions: HYPERPHAGIA
Phase: PHASE3 • Sponsor: Aardvark Therapeutics, Inc. • Aim: Disease control
Last updated May 26, 2026 08:59 UTC
-
Promising drug targets severe hunger in rare genetic disorder
Disease control OngoingThis study tests a daily injection called setmelanotide in 18 people aged 6 to 65 with Prader-Willi syndrome, a condition causing severe obesity and constant hunger. The goal is to see if the drug safely reduces body weight and controls appetite over 52 weeks. Participants must h…
Matched conditions: HYPERPHAGIA
Phase: PHASE2 • Sponsor: Rhythm Pharmaceuticals, Inc. • Aim: Disease control
Last updated May 26, 2026 08:34 UTC
-
Hope for rare hunger disorder: new drug trial targets Prader-Willi symptoms
Symptom relief TerminatedThis study tests whether the drug ARD-101 can reduce the intense, constant hunger (hyperphagia) seen in people with Prader-Willi syndrome. About 90 participants will take either ARD-101 or a placebo daily for 12 weeks. Researchers will track changes in hunger-related behaviors an…
Matched conditions: HYPERPHAGIA
Phase: PHASE3 • Sponsor: Aardvark Therapeutics, Inc. • Aim: Symptom relief
Last updated May 26, 2026 09:08 UTC
-
Gene hunt for severe childhood obesity launches in germany
Knowledge-focused OngoingThis study looks at 1000 people who may have a rare genetic form of obesity, like Bardet-Biedl syndrome. Researchers will use genetic testing to find the cause and better understand how these conditions affect the body. The goal is to improve early diagnosis and care for those wi…
Matched conditions: HYPERPHAGIA
Sponsor: Rolfs Consulting und Verwaltungs-GmbH (RCV) • Aim: Knowledge-focused
Last updated May 26, 2026 09:01 UTC